发明名称 Obesity inhibitory materials
摘要 Anti-obesity material of the present invention is absorbed in vivo by oral ingestion, drops, etc. so as to act against the causes of overeating and control food consumption, and it can thereby promote fat metabolism and control accumulation of body fat while at the same time can inhibit elevation of blood pressure, all without compromising immune system function, thus safely controlling an increase in body weight (obesity). There have previously been no anti-obesity materials like that of the present invention whatsoever. The main characteristic of the present invention is that an anti-obesity material having the above-described excellent effects is obtained since the anti-obesity material has isoflavone aglycone and/or isoflavone glycoside.
申请公布号 US2003082247(A1) 申请公布日期 2003.05.01
申请号 US20020070889 申请日期 2002.03.06
申请人 TAKEBE MINORU 发明人 TAKEBE MINORU
分类号 A23L1/29;A23L1/30;A61K31/352;A61P3/04;C07D311/36;(IPC1-7):A61K35/78;A61K31/704;A61K31/353 主分类号 A23L1/29
代理机构 代理人
主权项
地址